{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:28:07Z","timestamp":1774474087249,"version":"3.50.1"},"reference-count":193,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Pediatric Cardiology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.ppedcard.2009.09.004","type":"journal-article","created":{"date-parts":[[2009,11,16]],"date-time":"2009-11-16T09:48:31Z","timestamp":1258364911000},"page":"13-23","source":"Crossref","is-referenced-by-count":19,"title":["Non-congenital heart disease associated pediatric pulmonary arterial hypertension"],"prefix":"10.1016","volume":"27","author":[{"given":"D.D.","family":"Ivy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Feinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Humpl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.B.","family":"Rosenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ppedcard.2009.09.004_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1542\/peds.36.1.75","article-title":"Primary pulmonary vascular obstruction in children","volume":"36","author":"Thilenius","year":"1965","journal-title":"Pediatrics"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/0735-1097(94)00391-3","article-title":"Primary pulmonary hypertension in children: clinical characterization and survival","volume":"25","author":"Sandoval","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/adc.2003.048744","article-title":"Severe paediatric pulmonary hypertension: new management strategies","volume":"90","author":"Rashid","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/MOP.0b013e3282ff5fdc","article-title":"Pulmonary arterial hypertension in children: a medical update","volume":"20","author":"Rosenzweig","year":"2008","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib6","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1378\/chest.126.1_suppl.35S","article-title":"Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"Badesch","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1378\/chest.89.4.497","article-title":"Pharmacologically induced pulmonary vasodilatation in children and young adults with primary pulmonary hypertension","volume":"89","author":"Barst","year":"1986","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1136\/hrt.2008.150086","article-title":"Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001\u20132006","volume":"95","author":"Haworth","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib9","series-title":"Primary Pulmonary Hypertension World Health Orgnization","article-title":"Primary Pulmonary Hypertension. Executive Summary from the World Symposium","author":"Rich","year":"1998"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib10","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","article-title":"Diagnosis and assessment of pulmonary arterial hypertension","volume":"54","author":"Badesch","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib11","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.mop.0000163356.51027.c1","article-title":"Idiopathic pulmonary arterial hypertension in children","volume":"17","author":"Rosenzweig","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1055\/s-0029-1233308","article-title":"Genetics of pulmonary arterial hypertension","volume":"30","author":"Austin","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1203\/01.PDR.0000061565.22500.E7","article-title":"Insights into the genetic and molecular basis of primary pulmonary hypertension","volume":"53","author":"Trembath","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.CIR.0000153798.78540.87","article-title":"Transforming growth factor-beta receptor mutations and pulmonary arterial hypertension in childhood","volume":"111","author":"Harrison","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1203\/01.PDR.0000139481.20847.D0","article-title":"Primary pulmonary hypertension in children may have a different genetic background than in adults","volume":"56","author":"Grunig","year":"2004","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJM200108023450502","article-title":"Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred","volume":"345","author":"Newman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family","volume":"37","author":"Thomson","year":"2000","journal-title":"J Med Genet"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib19","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1378\/chest.111.6_Supplement.82S","article-title":"The presence of genetic anticipation suggests that the molecular basis of familial primary pulmonary hypertension may be trinucleotide repeat expansion","volume":"111","author":"Loyd","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.healun.2008.02.009","article-title":"Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension","volume":"27","author":"Rosenzweig","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib21","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/CIRCULATIONAHA.105.601930","article-title":"Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension","volume":"113","author":"Elliott","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1253\/circj.72.127","article-title":"Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension","volume":"72","author":"Fujiwara","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib23","first-page":"621","article-title":"The serotonin pathway in pulmonary hypertension","volume":"99","author":"Eddahibi","year":"2006","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1164\/rccm.200509-1361OC","article-title":"Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension","volume":"173","author":"Willers","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.healun.2009.01.016","article-title":"Polymorphism in the angiotensin II type 1 receptor (AGTR1) is associated with age at diagnosis in pulmonary arterial hypertension","volume":"28","author":"Chung","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/adc.2007.123653","article-title":"The 6-minute walk test: normal values for children of 4\u201311years of age","volume":"93","author":"Lammers","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib27","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.amjcard.2004.10.056","article-title":"Utility of cardiopulmonary stress testing in assessing disease severity in children with pulmonary arterial hypertension","volume":"95","author":"Yetman","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib29","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(97)00452-X","article-title":"Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension","volume":"31","author":"Nagaya","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1378\/chest.08-0187","article-title":"Brain natriuretic peptide levels in managing pediatric patients with pulmonary arterial hypertension","volume":"135","author":"Bernus","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijcard.2008.03.009","article-title":"Prognostic value of B-type natriuretic peptide in children with pulmonary hypertension","volume":"135","author":"Lammers","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1203\/PDR.0b013e318163a2e7","article-title":"Biological serum markers in the management of pediatric pulmonary arterial hypertension","volume":"63","author":"Van Albada","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1378\/chest.114.3.787","article-title":"The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension","volume":"114","author":"Rich","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1378\/chest.112.3.714","article-title":"The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension","volume":"112","author":"Frank","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib35","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM199207093270203","article-title":"The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension","volume":"327","author":"Rich","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib36","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1136\/hrt.2004.036491","article-title":"Fatal pulmonary arterial hypertension associated with phenylpropanolamine exposure","volume":"90","author":"Barst","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.CIR.85.1.249","article-title":"Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex","volume":"85","author":"Barst","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib38","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1378\/chest.119.6.1980","article-title":"Pulmonary arterial hypertension and thyroid disease","volume":"119","author":"Ferris","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib39","doi-asserted-by":"crossref","first-page":"618S","DOI":"10.1378\/chest.128.6_suppl.618S","article-title":"Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension: association with thyroid disease","volume":"128","author":"Roberts","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib40","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ppul.10363","article-title":"Lower airway obstruction, bronchial hyperresponsiveness, and primary pulmonary hypertension in children","volume":"37","author":"Rastogi","year":"2004","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1213\/01.ane.0000255732.16057.1c","article-title":"Perioperative complications in children with pulmonary hypertension undergoing noncardiac surgery or cardiac catheterization","volume":"104","author":"Carmosino","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1460-9592.2008.02419.x","article-title":"Anesthetic management of children with pulmonary arterial hypertension","volume":"18","author":"Friesen","year":"2008","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200605020-00005","article-title":"Pulmonary arterial hypertension : a comprehensive review of pharmacological treatment","volume":"5","author":"Berman Rosenzweig","year":"2006","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib44","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1161\/01.CIR.99.9.1197","article-title":"Vasodilator therapy for primary pulmonary hypertension in children","volume":"99","author":"Barst","year":"1999","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.1016\/j.ppedcard.2009.09.004_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2362.2006.01681.x","article-title":"Current treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan","volume":"36","author":"Beghetti","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib46","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1161\/CIRCULATIONAHA.104.488486","article-title":"Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension","volume":"111","author":"Sitbon","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib47","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/adc.2007.120493","article-title":"The management of pulmonary hypertension in children","volume":"93","author":"Haworth","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib48","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.0000138104.83366.E9","article-title":"Outcomes in children with idiopathic pulmonary arterial hypertension","volume":"110","author":"Yung","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib50","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1161\/01.CIR.88.5.2117","article-title":"Thromboxane A2 and prostacyclin biosynthesis in children and adolescents with pulmonary vascular disease","volume":"88","author":"Adatia","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib51","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib52","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/hrt.2006.096412","article-title":"Epoprostenol treatment in children with severe pulmonary hypertension","volume":"93","author":"Lammers","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib53","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.amjcard.2003.12.031","article-title":"Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan","volume":"93","author":"Ivy","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib54","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","article-title":"A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension","author":"Barst","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib55","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1183\/09031936.06.00044406","article-title":"Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil","volume":"28","author":"Barst","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib56","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1378\/chest.129.3.683","article-title":"Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: a prospective, multicenter, open-label, 12-week trial","volume":"129","author":"Tapson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib57","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.amjcard.2006.09.119","article-title":"Transition of stable pediatric patients with pulmonary arterial hypertension from intravenous epoprostenol to intravenous treprostinil","volume":"99","author":"Ivy","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib58","first-page":"170","article-title":"Bloodstream infections among patients treated with intravenous epoprostenol or intravenous treprostinil for pulmonary arterial hypertension\u2014seven sites, United States, 2003\u20132006","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib59","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1742-1241.2008.01811.x","article-title":"Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension","author":"Doran","year":"2008","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1086\/605320","article-title":"Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension","volume":"30","author":"Ivy","year":"2009","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib61","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2006.05.070","article-title":"Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in pulmonary arterial hypertension","volume":"48","author":"Channick","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib62","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJM200006223422503","article-title":"Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue","volume":"342","author":"Hoeper","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib63","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1164\/rccm.200603-358OC","article-title":"Randomized study of adding inhaled iloprost to existing bosentan in pulmonary arterial hypertension","volume":"174","author":"McLaughlin","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib64","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib65","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2007.09.031","article-title":"Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension","volume":"51","author":"Ivy","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ijcard.2007.08.084","article-title":"Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease","volume":"129","author":"Limsuwan","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib67","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00392-007-0490-3","article-title":"Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension","volume":"96","author":"Ewert","year":"2007","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib68","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0002-9149(03)00991-3","article-title":"Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease","volume":"92","author":"Hallioglu","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib69","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1016\/S0735-1097(02)01786-2","article-title":"Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial","volume":"39","author":"Galie","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib70","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0735-1097(03)00463-7","article-title":"Beraprost therapy for pulmonary arterial hypertension","volume":"41","author":"Barst","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib71","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib72","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev.med.59.110106.212434","article-title":"Role of endothelin receptor antagonists in the treatment of pulmonary arterial hypertension","volume":"60","author":"Abman","year":"2009","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib73","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib74","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0009-9236(03)00005-5","article-title":"Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension","volume":"73","author":"Barst","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib75","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jacc.2005.01.066","article-title":"Effects of long-term bosentan in children with pulmonary arterial hypertension","volume":"46","author":"Rosenzweig","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib76","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/hrt.2005.072314","article-title":"Response to bosentan in children with pulmonary hypertension","volume":"92","author":"Maiya","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib77","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1203\/PDR.0b013e318179954c","article-title":"Safety experience with bosentan in 146 children 2\u201311years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program","volume":"64","author":"Beghetti","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib78","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.jacc.2006.01.057","article-title":"Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan","volume":"47","author":"Barst","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib79","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1164\/rccm.200307-957OC","article-title":"Sitaxsentan therapy for pulmonary arterial hypertension","volume":"169","author":"Barst","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib80","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1161\/CIRCULATIONAHA.107.742510","article-title":"Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2","volume":"117","author":"Galie","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib81","first-page":"L931","article-title":"Chronic pulmonary hypertension increases fetal lung cGMP phosphodiesterase activity","volume":"275","author":"Hanson","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib82","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1161\/CIRCULATIONAHA.104.473371","article-title":"Beneficial effect of oral sildenafil therapy on childhood pulmonary arterial hypertension: twelve-month clinical trial of a single-drug, open-label, pilot study","volume":"111","author":"Humpl","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2004.09.002","article-title":"Safety and efficacy of sildenafil therapy in children with pulmonary hypertension","volume":"100","author":"Karatza","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib84","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib85","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1161\/01.CIR.0000016641.12984.DC","article-title":"Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide","volume":"105","author":"Michelakis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib86","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1161\/01.CIR.0000099502.17776.C2","article-title":"Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension","volume":"108","author":"Michelakis","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib87","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jacc.2003.10.056","article-title":"Clinical efficacy of sildenafil in primary pulmonary hypertension: a randomized, placebo-controlled, double-blind, crossover study","volume":"43","author":"Sastry","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib88","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1164\/rccm.200410-1411OC","article-title":"Sildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) study","volume":"171","author":"Wilkins","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib89","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1136\/heart.84.2.e4","article-title":"Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension","volume":"84","author":"Abrams","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib90","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM200011023431814","article-title":"Sildenafil in primary pulmonary hypertension","volume":"343","author":"Prasad","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib91","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1067\/mtc.2002.125265","article-title":"Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crisis","volume":"124","author":"Atz Am","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Suppl 1","key":"10.1016\/j.ppedcard.2009.09.004_bib92","first-page":"II167","article-title":"Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease","volume":"108","author":"Schulze-Neick","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib93","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1007\/s00134-003-2016-4","article-title":"Intravenous sildenafil and inhaled nitric oxide: a randomised trial in infants after cardiac surgery","volume":"29","author":"Stocker","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib94","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00000542-199907000-00041","article-title":"Sildenafil ameliorates effects of inhaled nitric oxide withdrawal","volume":"91","author":"Atz","year":"1999","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib95","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1164\/rccm.200605-694OC","article-title":"Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children","volume":"174","author":"Namachivayam","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib96","first-page":"510","article-title":"The Swiss registry for pulmonary arterial hypertension: the paediatric experience","volume":"137","author":"Fasnacht","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib97","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jpeds.2008.09.021","article-title":"Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease","volume":"154","author":"Mourani","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib98","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1440-1843.2007.01176.x","article-title":"Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study","volume":"13","author":"Bendayan","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib99","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0091270008315315","article-title":"Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects","volume":"48","author":"Wrishko","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib100","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ijcard.2007.01.046","article-title":"Sustained benefit of tadalafil in patients with pulmonary arterial hypertension with prior response to sildenafil: a case series of 12 patients","volume":"125","author":"Tay","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib101","doi-asserted-by":"crossref","first-page":"743","DOI":"10.7326\/0003-4819-141-9-200411020-00033","article-title":"Tadalafil in primary pulmonary arterial hypertension","volume":"141","author":"Palmieri","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib102","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/thorax.55.2.95","article-title":"Role of atrial septostomy in the treatment of pulmonary vascular disease","volume":"55","author":"Barst","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib103","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1161\/01.CIR.91.7.2028","article-title":"Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension","volume":"91","author":"Kerstein","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib104","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ccd.1810240305","article-title":"Effects of atrial septostomy in patients with terminal cor pulmonale due to pulmonary vascular disease","volume":"24","author":"Nihill","year":"1991","journal-title":"Cathet Cardiovasc Diagn"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0735-1097(98)00238-1","article-title":"Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment","volume":"32","author":"Sandoval","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib106","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJM200402053500623","article-title":"Potts shunt in patients with pulmonary hypertension","volume":"350","author":"Blanc","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib107","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib108","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1590\/S1806-37132008000900015","article-title":"Pulmonary veno-occlusive disease: diagnostic and therapeutic alternatives","volume":"34","author":"Barboza","year":"2008","journal-title":"J Bras Pneumol"},{"issue":"Suppl 6","key":"10.1016\/j.ppedcard.2009.09.004_bib109","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1055\/s-0028-1091242","article-title":"Pulmonary veno-occlusive disease \u2014 a rare form of pulmonary arterial hypertension","volume":"133","author":"Halank","year":"2008","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib110","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/thx.2007.088831","article-title":"Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil","volume":"63","author":"Creagh-Brown","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib111","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MD.0b013e31818193bb","article-title":"Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology","volume":"87","author":"Montani","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib112","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/1529-0131(200003)43:3<699::AID-ANR28>3.0.CO;2-O","article-title":"Pulmonary edema complicating prostacyclin therapy in pulmonary hypertension associated with scleroderma: a case of pulmonary capillary hemangiomatosis","volume":"43","author":"Gugnani","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib113","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1164\/ajrccm.157.5.9708065","article-title":"Pulmonary edema complicating continuous intravenous prostacyclin in pulmonary capillary hemangiomatosis","volume":"157","author":"Humbert","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib114","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1378\/chest.08-2006","article-title":"Failure of medical therapy in pulmonary arterial hypertension: is there an alternative diagnosis?","volume":"135","author":"Harch","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib115","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.2214\/ajr.160.6.8498252","article-title":"Pediatric case of the day. Pulmonary venoocclusive disease","volume":"160","author":"Matsumoto","year":"1993","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib116","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.rct.0000284393.76073.87","article-title":"Pulmonary capillary hemangiomatosis imaging findings and literature update","volume":"31","author":"El-Gabaly","year":"2007","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib117","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1148\/rg.273065194","article-title":"From the archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis","volume":"27","author":"Frazier","year":"2007","journal-title":"Radiographics"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib118","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/01.pas.0000209834.69972.e5","article-title":"Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases","volume":"30","author":"Lantuejoul","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib119","first-page":"483","article-title":"Acute pulmonary oedema in patients with primary pulmonary hypertension and normal pulmonary capillary wedge pressure","volume":"49","author":"Van Mieghem","year":"1994","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib120","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rti.0000139390.26138.94","article-title":"Pulmonary capillary hemangiomatosis: multidetector row CT findings and clinico-pathologic correlation","volume":"20","author":"Lawler","year":"2005","journal-title":"J Thorac Imaging"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib121","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1183\/09031936.00054407","article-title":"Possible role of imatinib in clinical pulmonary veno-occlusive disease","volume":"32","author":"Overbeek","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib122","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-3476(05)81844-X","article-title":"Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a","volume":"118","author":"White","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib123","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1378\/chest.124.5.2017","article-title":"Pulmonary capillary hemangiomatosis with atypical endotheliomatosis: successful antiangiogenic therapy with doxycycline","volume":"124","author":"Ginns","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib124","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1378\/chest.06-1680","article-title":"Platelet-derived growth factor is increased in pulmonary capillary hemangiomatosis","volume":"131","author":"Assaad","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib125","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajh.21057","article-title":"Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology, pathophysiology, and management","volume":"83","author":"Aliyu","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib126","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.hoc.2005.07.007","article-title":"Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management","volume":"19","author":"Castro","year":"2005","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib127","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib128","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMra0804411","article-title":"Pulmonary complications of sickle cell disease","volume":"359","author":"Gladwin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.2007-0730","article-title":"Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease","volume":"121","author":"Pashankar","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib130","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0735-1097(87)80305-4","article-title":"Cardiac performance in children with homozygous sickle cell disease","volume":"9","author":"Chung","year":"1987","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib131","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.jacc.2006.03.005","article-title":"Evaluation of left ventricular systolic function in pediatric sickle cell anemia patients using the end-systolic wall stress\u2013velocity of circumferential fiber shortening relationship","volume":"47","author":"Lamers","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib132","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2141.2008.07501.x","article-title":"Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease","volume":"144","author":"Pashankar","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib133","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ajh.21039","article-title":"Severe pulmonary hypertension in an adolescent with sickle cell disease","volume":"83","author":"Taylor","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib134","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jpeds.2008.01.042","article-title":"Symptomatic pulmonary hypertension in a child with sickle cell disease","volume":"152","author":"Villavicencio","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib135","first-page":"94","article-title":"Pulmonary capillary hemangiomatosis: a unique feature of congestive vasculopathy associated with hypertrophic cardiomyopathy","volume":"122","author":"Jing","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib136","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00003072-199112000-00007","article-title":"Lung scintigraphy in pulmonary capillary hemangiomatosis. A rare disorder causing primary pulmonary hypertension","volume":"16","author":"Rush","year":"1991","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib137","first-page":"3","article-title":"Angiogenesis and its inhibition: potential new therapies in oncology and non-neoplastic diseases","volume":"8","author":"Billington","year":"1991","journal-title":"Drug Des Discov"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib138","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5858\/2001-125-1436-PTAIPW","article-title":"Pulmonary thrombotic arteriopathy in patients with sickle cell disease","volume":"125","author":"Adedeji","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib139","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jacc.2006.09.038","article-title":"Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease","volume":"49","author":"Sachdev","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib140","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2174\/156652408786241447","article-title":"Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders","volume":"8","author":"Morris","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib141","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib142","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2141.2005.05701.x","article-title":"Levels of soluble endothelium-derived adhesion molecules in patients with sickle cell disease are associated with pulmonary hypertension, organ dysfunction, and mortality","volume":"130","author":"Kato","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib143","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1182\/blood-2006-12-061697","article-title":"Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin","volume":"110","author":"Villagra","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib144","first-page":"452","article-title":"Efficacy and safety of sildenafil in the treatment of severe pulmonary hypertension in patients with hemoglobinopathies","volume":"90","author":"Derchi","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2141.2005.05625.x","article-title":"Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension","volume":"130","author":"Machado","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib146","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/01.CCM.0000153595.76419.F3","article-title":"The distinct concepts and implications of hepatopulmonary syndrome and portopulmonary hypertension","volume":"33","author":"Krowka","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib147","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(04)16107-2","article-title":"Portopulmonary hypertension and hepatopulmonary syndrome","volume":"363","author":"Hoeper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib148","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccm.2005.06.010","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: implications for liver transplantation","volume":"26","author":"Krowka","year":"2005","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib149","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/lt.20016","article-title":"Hepatopulmonary syndrome and portopulmonary hypertension: a report of the multicenter liver transplant database","volume":"10","author":"Krowka","year":"2004","journal-title":"Liver Transplant"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib150","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/lt.500060116","article-title":"Clinical predictors of pulmonary hypertension in patients undergoing liver transplant evaluation","volume":"6","author":"Pilatis","year":"2000","journal-title":"Liver Transplant"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib151","doi-asserted-by":"crossref","unstructured":"Swanson KL, Krowka MJ. Screen for portopulmonary hypertension, especially in liver transplant candidates. Cleve Clin J Med 2008;75:121\u20132, 5\u201330, 33 passim.","DOI":"10.3949\/ccjm.75.2.121"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib152","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1600-6143.2008.02384.x","article-title":"Survival in portopulmonary hypertension: mayo clinic experience categorized by treatment subgroups","volume":"8","author":"Swanson","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib153","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00007890-200102270-00015","article-title":"Role of Doppler echocardiography in the assessment of portopulmonary hypertension in liver transplantation candidates","volume":"71","author":"Torregrosa","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib154","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.jpedsurg.2008.04.002","article-title":"Liver transplantation for pulmonary vascular complications of pediatric end-stage liver disease","volume":"43","author":"Iqbal","year":"2008","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2350\/08-05-0093.1","article-title":"Portopulmonary hypertension in childhood presenting as sudden death","volume":"9","author":"Weber","year":"2006","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib156","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.mpg.0000178441.10417.0f","article-title":"Successful liver transplantation in a child with severe portopulmonary hypertension treated with epoprostenol","volume":"41","author":"Laving","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib157","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/j.1536-4801.2005.tb00002.x","article-title":"Hepato-portopulmonary disorders\u2014not just in adults!","volume":"41","author":"Whitworth","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib158","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2005.02.019","article-title":"Portopulmonary hypertension in pediatric patients","volume":"147","author":"Condino","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib159","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpeds.2005.04.014","article-title":"Many faces of portopulmonary hypertension","volume":"147","author":"Krowka","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib160","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1002\/hep.20244","article-title":"The role of endothelin-1 and the endothelin B receptor in the pathogenesis of hepatopulmonary syndrome in the rat","volume":"39","author":"Ling","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib161","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jpeds.2005.02.019","article-title":"Portopulmonary hypertension in pediatric patients","volume":"147","author":"Condino","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib162","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/01.meg.0000231749.60889.f7","article-title":"Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency","volume":"18","author":"Barth","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib163","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1183\/09031936.05.00080804","article-title":"Bosentan therapy for portopulmonary hypertension","volume":"25","author":"Hoeper","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib164","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1183\/09031936.00032407","article-title":"Experience with inhaled iloprost and bosentan in portopulmonary hypertension","volume":"30","author":"Hoeper","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00246-002-0120-9","article-title":"Moderate-term effect of epoprostenol on severe portopulmonary hypertension","volume":"24","author":"Kato","year":"2003","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib166","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1183\/09031936.06.00086506","article-title":"How should we treat portopulmonary hypertension?","volume":"28","author":"Krowka","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib167","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0971-9784.41595","article-title":"Bosentan for the treatment of portopulmonary hypertension","volume":"11","author":"Tempe","year":"2008","journal-title":"Ann Card Anaesth"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib168","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0046-8177(87)80417-3","article-title":"Membranoproliferative glomerulonephritis and plexogenic pulmonary arteriopathy in a homosexual man with acquired immunodeficiency syndrome","volume":"18","author":"Kim","year":"1987","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib169","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1378\/chest.101.2.474","article-title":"Pulmonary hypertension and human immunodeficiency virus infection. Two reports and a review of the literature","volume":"101","author":"Polos","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib170","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1378\/chest.100.5.1268","article-title":"Primary pulmonary hypertension in HIV infection","volume":"100","author":"Speich","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib171","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1086\/383037","article-title":"Pulmonary arterial hypertension related to HIV infection: improved hemodynamics and survival associated with antiretroviral therapy","volume":"38","author":"Zuber","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib172","first-page":"233","article-title":"Cardiac longitudinal study of children perinatally exposed to human immunodeficiency virus type 1","volume":"85","author":"Diogenes","year":"2005","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib173","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1179\/027249304225013439","article-title":"Cardiac manifestations in HIV-infected Thai children","volume":"24","author":"Pongprot","year":"2004","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib174","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1378\/chest.118.4.1133","article-title":"HIV-related pulmonary hypertension: analytic review of 131 cases","volume":"118","author":"Mehta","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib175","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1177\/000331970105200105","article-title":"Primary pulmonary hypertension in HIV patients: a systematic review","volume":"52","author":"Pellicelli","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib176","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","article-title":"Pulmonary arterial hypertension in France: results from a national registry","volume":"173","author":"Humbert","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib177","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0735-1097(98)00449-5","article-title":"Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland","volume":"32","author":"Lai","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib178","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00126334-200501010-00016","article-title":"Risk factors for in utero and intrapartum transmission of HIV","volume":"38","author":"Magder","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib179","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5694\/j.1326-5377.2009.tb02488.x","article-title":"Perinatal exposure to HIV among children born in Australia, 1982\u20132006","volume":"190","author":"McDonald","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10024-003-1001-9","article-title":"Cardiac, aortic, and pulmonary arteriopathy in HIV-infected children: the prospective P2C2 HIV multicenter study","volume":"7","author":"Perez-Atayde","year":"2004","journal-title":"Pediatr Dev Pathol"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib181","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/ajrccm\/145.5.1196","article-title":"Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy","volume":"145","author":"Mette","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib182","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00007611-200106000-00018","article-title":"Pulmonary hypertension associated with HIV infection","volume":"94","author":"Seoane","year":"2001","journal-title":"South Med J"},{"issue":"Suppl 3","key":"10.1016\/j.ppedcard.2009.09.004_bib183","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/01.aids.0000327515.55041.da","article-title":"Mediators involved in HIV-related pulmonary arterial hypertension","volume":"22","author":"Humbert","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib184","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.98.11030554","article-title":"Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients","volume":"11","author":"Humbert","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2459\/01.JCM.0000223264.85298.81","article-title":"Cardiovascular monitoring of HIV-infected patients","volume":"7","author":"Barbaro","year":"2006","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib186","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1164\/ajrccm.155.3.9117037","article-title":"HIV-associated primary pulmonary hypertension. A case control study. Swiss HIV Cohort Study","volume":"155","author":"Opravil","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib187","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.clpt.2005.04.005","article-title":"Pharmacokinetic interactions between indinavir plus ritonavir and calcium channel blockers","volume":"78","author":"Glesby","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib188","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/FTD.0b013e318165ba71","article-title":"Pharmacokinetics and pharmacodynamics of sildenafil in a patient treated with human immunodeficiency virus protease inhibitors","volume":"30","author":"Aschmann","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib189","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1097\/00002030-200207260-00021","article-title":"Sildenafil as a successful treatment of otherwise fatal HIV-related pulmonary hypertension","volume":"16","author":"Carlsen","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib190","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1440-1754.2006.00816.x","article-title":"Sildenafil as treatment for Human Immunodeficiency Virus-related pulmonary hypertension in a child","volume":"42","author":"Wong","year":"2006","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib191","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1183\/09031936.00094808","article-title":"Long-term effects of bosentan in patients with HIV-associated pulmonary arterial hypertension","volume":"33","author":"Degano","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib192","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1164\/ajrccm.162.5.2004042","article-title":"Epoprostenol (prostacyclin) therapy in HIV-associated pulmonary hypertension","volume":"162","author":"Aguilar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ppedcard.2009.09.004_bib193","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1161\/CIRCULATIONAHA.105.546465","article-title":"What a cardiologist needs to know about patients with human immunodeficiency virus infection","volume":"112","author":"Hsue","year":"2005","journal-title":"Circulation"}],"container-title":["Progress in Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1058981309000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1058981309000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T17:09:03Z","timestamp":1710695343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1058981309000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":193,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S1058981309000277"],"URL":"https:\/\/doi.org\/10.1016\/j.ppedcard.2009.09.004","relation":{},"ISSN":["1058-9813"],"issn-type":[{"value":"1058-9813","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}